Literature DB >> 11280454

Lyme disease--United States, 1999.

.   

Abstract

Lyme disease (LD) is caused by the tickborne spirochete Borrelia burgdorferi sensu lato and is the most common vectorborne disease in the United States. Surveillance for LD was initiated by CDC in 1982, and the Council of State and Territorial Epidemiologists designated it a nationally notifiable disease in January 1991. This report summarizes the number of LD cases reported to CDC during 1999. Although the number of cases decreased from 1998, the number of cases in 1999 was higher than the number reported during the early 1990s. LD can be prevented by avoiding tick-infested habitats, by using personal protective measures, by vaccination, by checking for and removing ticks attached to the body and clothes, and by reducing tick populations.

Entities:  

Mesh:

Year:  2001        PMID: 11280454

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

Review 1.  Laboratory testing for Lyme disease: possibilities and practicalities.

Authors:  Kurt D Reed
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Patterns of Lyme disease diagnosis and treatment by family physicians in a southeastern state.

Authors:  John M Boltri; Robert B Hash; Robert L Vogel
Journal:  J Community Health       Date:  2002-12

3.  Effects of vlsE complementation on the infectivity of Borrelia burgdorferi lacking the linear plasmid lp28-1.

Authors:  Matthew B Lawrenz; R Mark Wooten; Steven J Norris
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.

Authors:  Maria J C Gomes-Solecki; Gary P Wormser; Martin Schriefer; Glenn Neuman; Laura Hannafey; John D Glass; Raymond J Dattwyler
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

5.  The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans.

Authors:  Daniel E Dykhuizen; Dustin Brisson; Sabina Sandigursky; Gary P Wormser; John Nowakowski; Robert B Nadelman; Ira Schwartz
Journal:  Am J Trop Med Hyg       Date:  2008-05       Impact factor: 2.345

6.  Endemic babesiosis in another eastern state: New Jersey.

Authors:  Barbara L Herwaldt; Paul C McGovern; Michal P Gerwel; Rachael M Easton; Rob Roy MacGregor
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

7.  Genetic diversity of the outer surface protein C gene of southern Borrelia isolates and its possible epidemiological, clinical, and pathogenetic implications.

Authors:  Tao Lin; James H Oliver; Lihui Gao
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

8.  Whole-genome DNA array analysis of the response of Borrelia burgdorferi to a bactericidal monoclonal antibody.

Authors:  Julie M Anderton; Rafal Tokarz; Charles D Thill; Christopher J Kuhlow; Chad S Brooks; Darrin R Akins; Laura I Katona; Jorge L Benach
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 9.  Lyme disease and current aspects of immunization.

Authors:  Thomas Kamradt
Journal:  Arthritis Res       Date:  2001-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.